Cargando…

PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma

SIMPLE SUMMARY: This article assesses the efficacy and safety of cemiplimab and pembrolizumab within a complex cohort of cancer patients diagnosed with locally advanced cutaneous squamous cell carcinoma or metastatic cutaneous squamous cell carcinoma. This cohort encompassed individuals with immunos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yakobson, Alexander, Abu Jama, Ashraf, Abu Saleh, Omar, Michlin, Regina, Shalata, Walid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452426/ https://www.ncbi.nlm.nih.gov/pubmed/37627069 http://dx.doi.org/10.3390/cancers15164041

Ejemplares similares

Unexpected and Rare Sites of Metastasis in Oncologic Patients
por: Shalata, Walid, et al.
Publicado: (2023)

Is Elevation of Alkaline Phosphatase a Predictive Factor of Response to Alectinib in NSCLC?
por: Shalata, Walid, et al.
Publicado: (2021)

A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2022)

Dermatomyositis Associated with Lung Cancer: A Brief Review of the Current Literature and Retrospective Single Institution Experience
por: Shalata, Walid, et al.
Publicado: (2022)

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma
por: Shalata, Walid, et al.
Publicado: (2023)

Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience
por: Rouvinov, Keren, et al.
Publicado: (2023)

Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review
por: Shalata, Walid, et al.
Publicado: (2023)

Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer
por: Shalata, Walid, et al.
Publicado: (2023)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023)

Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors
por: Yakobson, Alexander, et al.
Publicado: (2023)

Long-Lasting Therapeutic Response following Treatment with Pembrolizumab in Patients with Non-Small Cell Lung Cancer: A Real-World Experience
por: Shalata, Walid, et al.
Publicado: (2023)

Radiotherapy-Induced Atrial Myxoma: A Case Report and Literature Review
por: Shalata, Walid, et al.
Publicado: (2023)

Associated Myocarditis: A Predictive Factor for Response?
por: Shalata, Walid, et al.
Publicado: (2020)

Bullous Pemphigoid Occurring after Stopping Imatinib Therapy of CML: Is a Continuation of Post-Treatment Follow-Up Needed?
por: Yakobson, Alexander, et al.
Publicado: (2023)

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review
por: Shalata, Walid, et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future
por: Szeto, Chun Ho, et al.
Publicado: (2021)

Disseminated Mycobacterium genavense in the immunocompromised: A Case Series at Mayo Clinic Rochester
por: Mahmood, Maryam, et al.
Publicado: (2017)

Management of Cutaneous Head and Neck Squamous and Basal Cell Carcinomas for Immunocompromised Patients
por: Bommakanti, Krishna K., et al.
Publicado: (2023)

Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma
por: Clingan, Philip, et al.
Publicado: (2023)

Cytomegalovirus Cutaneous Infection in an Immunocompromised Patient
por: Fasanya, Adebayo A, et al.
Publicado: (2016)

Cutaneous fungal infection in an immunocompromised host
por: Sotello, David, et al.
Publicado: (2017)

Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer
por: Chen, Beibei, et al.
Publicado: (2022)

Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients—A Comparison between Different Immunomodulating Conditions
por: Zavdy, Ofir, et al.
Publicado: (2023)

Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective survey
por: Samaran, Quentin, et al.
Publicado: (2022)

Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
por: Oro-Ayude, Marcos, et al.
Publicado: (2020)

Metastatic zosteriform cutaneous squamous cell carcinoma
por: Crevier-Sorbo, Gabriel, et al.
Publicado: (2021)

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
por: Falchook, Gerald S., et al.
Publicado: (2016)

Complete Resolution of a Large, Locally-advanced Cutaneous Squamous Cell Carcinoma with the Immune-modulating PD-1 Inhibitor Pembrolizumab
por: Cristancho, Cagney, et al.
Publicado: (2020)

Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 Vaccination
por: Shalata, Walid, et al.
Publicado: (2022)

Isoscartopic Response: Another Facet of the Immunocompromised Cutaneous District
por: Caccavale, Stefano, et al.
Publicado: (2016)

Cutaneous mucormycosis in an immunocompromised patient: a case report
por: Suthananthan, Arul E., et al.
Publicado: (2017)

Bullous Scabies in an Immunocompromised Host
por: Wester, James R., et al.
Publicado: (2022)

Cutaneous leishmaniasis in a returned traveler
por: Kundu, Rupayan, et al.
Publicado: (2022)

Effect of Propolis on Experimental Cutaneous Wound Healing in Dogs
por: Abu-Seida, Ashraf M.
Publicado: (2015)

Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future
por: Shalata, Walid, et al.
Publicado: (2021)

Cave diving for a diagnosis: Disseminated histoplasmosis in the immunocompromised
por: Mirza, Abu-Sayeef, et al.
Publicado: (2018)

Prognostic factors for metastatic cutaneous squamous cell carcinoma of the parotid
por: Makki, Fawaz M, et al.
Publicado: (2013)

Sporotrichoid-Like Spread of Cutaneous Mycobacterium chelonae in an Immunocompromised Patient
por: Kemp, Daria Marley, et al.
Publicado: (2017)

Immunocompromised Cutaneous District Revisited: Florid Scabies in Paralytic Limb
por: Taneja, Gargi, et al.
Publicado: (2020)

Cutaneous Leishmaniasis in an Immunocompromised Pediatric Patient With Acute Lymphoblastic Leukemia
por: Cohen, Stephanie R, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_63uiavgcj5c92nrthj714ad8fo